Cost-effectiveness of Preventive Therapy for Tuberculosis with Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings

Karl T. Johnson, Gavin J. Churchyard, Hojoon Sohn, David W. Dowdy

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness of Preventive Therapy for Tuberculosis with Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings'. Together they form a unique fingerprint.

Medicine & Life Sciences